# Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

> **NCT03259230** · — · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 40 (actual)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **OTHER:** Blood Draws
- **OTHER:** Data Collection

## Key facts

- **NCT ID:** NCT03259230
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-13
- **Primary completion:** 2020-01-29
- **Final completion:** 2020-01-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03259230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03259230, "Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03259230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*